Leaflet AREDIA 15mg lyophilisate and solvent for solution for infusion
Indicated for: bone metastases; tumor-induced hypercalcemia
Route of administration: infusion
Substance: pamidronic acid (bisphosphonate)
ATC: M05BA03 (Musculo-skeletal system | Drugs affecting bone structure and mineralization | Bisphosphonates)
Take this medicine on an empty stomach.
Do not take with milk, calcium, iron, magnesium, or antacids if separation is recommended.
Pamidronic acid is a bisphosphonate used to treat hypercalcemia associated with cancer and to prevent skeletal complications in patients with bone metastases. It works by inhibiting osteoclast-mediated bone resorption, thereby reducing bone loss.
It is administered intravenously and is effective in lowering high calcium levels in the blood, which can occur in certain types of cancer. It is also used to reduce the risk of bone fractures and other complications in patients with bone metastases.
Common side effects include fever, flu-like symptoms, and bone or muscle pain. In rare cases, it may cause osteonecrosis of the jaw, especially in patients who have recently undergone dental procedures.
Patients receiving pamidronic acid treatment should be monitored for kidney function, as the drug can affect the kidneys, particularly at high doses.
General data about AREDIA 15mg
- Substance: pamidronic acid
- Date of latest medicines list: 01-01-2019
- Product code: W07918001
- Concentration: 15mg
- Pharmaceutical form: lyophilisate and solvent for solution for infusion
- Quantity: 4
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for pamidronic acid
Concentrations available for pamidronic acid
- 15mg
- 15mg/ml
- 30mg
- 3mg/ml
- 60mg
- 6mg/ml
- 9mg/ml